CARGO Therapeutics, Inc. financial data

Location
San Carlos, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 06 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1124% % -3.8%
Debt-to-equity 16% % -8.4%
Return On Equity -69% % -30%
Return On Assets -60% % -46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48,364,311 shares 5.4%
Common Stock, Shares, Outstanding 46,042,504 shares 12%
Common Stock, Value, Issued $46,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 48,133,609 shares 11%
Weighted Average Number of Shares Outstanding, Diluted 48,133,609 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $113,582,000 USD -3.1%
General and Administrative Expense $41,610,000 USD 14%
Operating Income (Loss) $238,570,000 USD -55%
Net Income (Loss) Attributable to Parent $221,778,000 USD -50%
Earnings Per Share, Basic -4 USD/shares -116%
Earnings Per Share, Diluted -4 USD/shares -116%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $107,746,000 USD -30%
Marketable Securities, Current $144,821,000 USD -50%
Assets, Current $258,605,000 USD -42%
Property, Plant and Equipment, Net $1,112,000 USD -90%
Operating Lease, Right-of-Use Asset $22,933,000 USD -15%
Other Assets, Noncurrent $93,000 USD -98%
Assets $258,605,000 USD -47%
Accounts Payable, Current $8,668,000 USD 24%
Employee-related Liabilities, Current $25,000 USD -99%
Accrued Liabilities, Current $739,000 USD -87%
Liabilities, Current $20,908,000 USD -21%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $20,908,000 USD -61%
Accumulated Other Comprehensive Income (Loss), Net of Tax $9,000 USD 97%
Retained Earnings (Accumulated Deficit) $447,083,000 USD -98%
Stockholders' Equity Attributable to Parent $237,697,000 USD -45%
Liabilities and Equity $258,605,000 USD -47%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $37,693,000 USD -25%
Net Cash Provided by (Used in) Investing Activities $35,042,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 46,042,504 shares 12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,613,000 USD 99%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $108,313,000 USD -30%
Deferred Tax Assets, Valuation Allowance $89,663,000 USD 195%
Deferred Tax Assets, Gross $95,575,000 USD 158%
Operating Lease, Liability $578,000 USD -98%
Depreciation $2,216,000 USD 4%
Payments to Acquire Property, Plant, and Equipment $382,000 USD -70%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $221,464,000 USD -50%
Lessee, Operating Lease, Liability, to be Paid $584,000 USD -99%
Property, Plant and Equipment, Gross $1,310,000 USD -90%
Operating Lease, Liability, Current $578,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,441,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,225,000 USD 55%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure -7.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14,679,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,664,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $20,840,000 USD 815%
Unrecognized Tax Benefits $4,508,000 USD 265%
Lessee, Operating Lease, Liability, to be Paid, Year Four $7,894,000 USD
Operating Lease, Payments $0 USD -100%
Additional Paid in Capital $684,743,000 USD 3.5%
Deferred Tax Assets, Net of Valuation Allowance $0 USD